You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Strides Pharma Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for STRIDES PHARMA, and what generic and branded alternatives to STRIDES PHARMA drugs are available?

STRIDES PHARMA has two hundred and forty-four approved drugs.

There are three tentative approvals on STRIDES PHARMA drugs.

Summary for Strides Pharma
US Patents:0
Tradenames:153
Ingredients:149
NDAs:244
Patent Litigation for Strides Pharma: See patent lawsuits for Strides Pharma

Drugs and US Patents for Strides Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Strides Pharma PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 075938-003 Oct 17, 2002 AB RX No Yes ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma TORSEMIDE torsemide TABLET;ORAL 076226-004 May 27, 2003 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma DUTASTERIDE dutasteride CAPSULE;ORAL 204262-001 Nov 20, 2015 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma TORSEMIDE torsemide TABLET;ORAL 090613-001 Mar 22, 2011 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma TRANYLCYPROMINE SULFATE tranylcypromine sulfate TABLET;ORAL 040640-001 Jun 29, 2006 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma OMEPRAZOLE AND SODIUM BICARBONATE omeprazole; sodium bicarbonate CAPSULE;ORAL 078966-001 May 25, 2010 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Strides Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Strides Pharma ACCOLATE zafirlukast TABLET;ORAL 020547-003 Sep 17, 1999 5,612,367 ⤷  Try a Trial
Strides Pharma CAPOTEN captopril TABLET;ORAL 018343-007 Jun 13, 1995 4,105,776 ⤷  Try a Trial
Strides Pharma CAPOTEN captopril TABLET;ORAL 018343-003 Approved Prior to Jan 1, 1982 4,105,776 ⤷  Try a Trial
Strides Pharma VEPESID etoposide CAPSULE;ORAL 019557-001 Dec 30, 1986 3,524,844 ⤷  Try a Trial
Strides Pharma CAPOTEN captopril TABLET;ORAL 018343-002 Approved Prior to Jan 1, 1982 5,238,924 ⤷  Try a Trial
Strides Pharma CAPOTEN captopril TABLET;ORAL 018343-002 Approved Prior to Jan 1, 1982 4,105,776 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for STRIDES PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
➤ Subscribe Tablets 10 mg and 20 mg ➤ Subscribe 2008-02-29
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.